Trish Regan has the news on rumors about Elon Musk buying MSNBC. Plus, while he’s …
Read More »First drug proven to slow Alzheimer’s won’t be available to most patients for several months
The first drug proven to slow Alzheimer’s is on sale, but most U.S. patients will not be able to receive the treatment for several months. Experts say some reasons behind the slow debut for Leqembi, from Japanese drugmaker Eisai, are minimal insurance coverage and many health systems requiring a setup …
Read More »